Sambucus ebulus, commonly called dwarf elder or danewort, is a perennial herbaceous plant in the elder family that has been used in folk medicine across Europe and western Asia for centuries, yet remains largely unknown outside those regions. Unlike its tall, tree-like relative Sambucus nigra (the common elderberry now popular in syrups and supplements), dwarf elder grows close to the ground, spreads aggressively by rhizome, and carries a reputation for toxicity that has kept it off store shelves. The science behind this plant, though, tells a more complicated story: researchers have found a surprisingly rich chemical profile and a wide range of biological activities in laboratory and animal studies that make it one of the more intriguing understudied medicinal plants in Europe.
A Long History in Folk Medicine
Dwarf elder has been used traditionally to treat joint pain, colds, wounds, and infections across a broad swath of its native range, from the Iberian Peninsula through Turkey and into the Caucasus.1PubMed Central. Biological Effects and Clinical Applications of Dwarf Elder (Sambucus ebulus L): A Review In Turkish folk medicine specifically, the leaves have been applied to treat high fever, rheumatic pain, snake bites, and wounds.2PubMed. Wound healing potential of Sambucus ebulus L. leaves and isolation of an active component, quercetin 3-O-glucoside Different communities used different parts of the plant for different purposes: roots and rhizomes as diuretics and anti-inflammatory agents, leaves as poultices for wounds, and fruits as laxatives or fever reducers. The breadth of these traditional applications is what first attracted modern researchers to look more closely at what compounds dwarf elder actually contains.
What Is Inside the Plant
Dwarf elder is chemically rich, and the profile changes depending on which part of the plant you analyze. One phytochemical survey of the leaves and flowers identified twelve phenylpropanoids in methanol extracts, including four hydroxycinnamic acids, three hydroxybenzoic acids, four flavonoids, and one catechin. Among those, sinapic acid was the most abundant compound in both leaves and flowers. Water extracts turned up fourteen amino acids, with glutamic acid predominating in leaves and valine in flowers.3PubMed Central. Leaf and Flower Extracts from the Dwarf Elder (Sambucus ebulus): Toxicity and Repellence against Cosmopolitan Mosquito-Borne Diseases Vectors
Flavonoid content varies considerably across organs and seasons. In one comparative study of Sambucus ebulus and its better-known relative Sambucus nigra, the flowers of dwarf elder contained about 5.6% flavonoids, while its green fruits held roughly 2.8%. Leaves came in around 4.9%, and the roots had the least at about 0.7%.4Bulletin of Science and Practice. Dynamics of Accumulation of Flavonoids in Different Organs of Sambucus nigra and S. ebulus These numbers are broadly comparable to those found in S. nigra, which may come as a surprise given how much more commercial attention the common elderberry receives.
Other research has identified gallic acid, catechin, and caffeic acid as major components in subcritical water extracts of the leaves, and these compounds appear to be closely linked to the plant’s observed biological activities.5Journal of Chemical Technology & Biotechnology. A new source for developing multi‐functional products: biological and chemical perspectives on subcritical water extracts of Sambucus ebulus L. Among the plant’s more unusual chemical inhabitants are the ribosome-inactivating proteins, or RIPs, including a family of compounds called ebulins. These are enzymes that can shut down protein synthesis in cells, which is central both to the plant’s toxicity and, paradoxically, to its potential medicinal interest.
Anti-Inflammatory and Pain-Relieving Effects
The folk use of dwarf elder for joint pain and inflammation has some laboratory backing. Two iridoid compounds isolated from the plant, called sambulin A and sambulin B, showed strong anti-inflammatory effects in cell-based experiments. Sambulin A reduced nitric oxide production by about 53% in inflammatory immune cells, while sambulin B was even more potent, cutting it by roughly 73% at a lower concentration. Both compounds also suppressed the inflammatory signaling molecule TNF-alpha, and sambulin B additionally blocked production of IL-6, another key driver of inflammation.6PubMed. Sambulin A and B, non-glycosidic iridoids from Sambucus ebulus, exert significant in vitro anti-inflammatory activity in LPS-induced RAW 264.7 macrophages via inhibition of MAPKs’s phosphorylation These are cell culture results, not human trial data, but they help explain why traditional healers found the plant effective against pain and swelling.
Animal studies tell a similar story. An early study using rat pain models found that an extract of Sambucus ebulus rhizome had both pain-relieving and anti-inflammatory properties. In one model measuring acute pain, the extract at moderate doses significantly increased the animals’ tolerance to pain. In a chronic pain model, the extract reduced pain behavior in both the early phase (linked to direct nerve stimulation) and the late phase (linked to inflammation). The pain-relieving effect was not reversed by naloxone, which means the mechanism is probably not working through the opioid system.7PubMed. Antinociceptive and anti-inflammatory effects of Sambucus ebulus rhizome extract in rats That distinction matters because non-opioid pain relievers generally carry a lower risk of dependence.
Wound Healing
Some of the most promising research on dwarf elder involves wound repair, which aligns neatly with its centuries-old use as a poultice plant. A study using diabetic rats found that a 5% fruit extract of Sambucus ebulus significantly improved wound closure rates compared to untreated controls. The treated wounds showed more new skin formation, greater collagen deposition, and higher fibroblast activity, while inflammatory markers and mast cell counts dropped.8Journal of Mazandaran University of Medical Sciences. Evaluation of Sambucus ebulus Fruit Extract in Full-Thickness Diabetic Wound Healing in Rats Diabetic wounds are notoriously slow to heal due to chronic inflammation and impaired blood vessel formation, so the fact that the extract addressed multiple aspects of the healing process at once is worth noting.
Another study tested topical ointments prepared from Sambucus ebulus extract, nettle (Urtica dioica) extract, and a combination of both on full-thickness wound models. All three preparations promoted healing, but the combination at a 2% concentration outperformed the individual extracts alone, suggesting a synergistic effect between the two plants.9Asian Pacific Journal of Tropical Biomedicine. The healing effects of herbal preparations from Sambucus ebulus and Urtica dioica in full-thickness wound models Researchers isolated quercetin 3-O-glucoside from dwarf elder leaves as one of the active wound-healing compounds, which connects back to the flavonoid-rich chemical profile described earlier.10PubMed. Wound healing potential of Sambucus ebulus L. leaves and isolation of an active component, quercetin 3-O-glucoside
Antimicrobial Activity, Including Against Drug-Resistant Bacteria
Drug-resistant infections are one of the more pressing problems in modern medicine, and researchers have screened dwarf elder extracts against some of the worst offenders. A study testing methanolic extracts of Sambucus ebulus against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) found that all test bacteria were sensitive to the extract. The minimum inhibitory concentration against a standard S. aureus strain was 15 mg, which was actually lower (meaning more potent) than nettle extract tested alongside it.11PubMed Central. Antimicrobial activity of methanolic extracts of Sambucus ebulus and Urtica dioica against clinical isolates of methicillin resistant Staphylococcus aureus The authors concluded that the extract could serve as a natural antiseptic. That said, the jump from a lab dish to a clinical wound care product is large, and no human antimicrobial trials have been published yet.
Antiviral and Anticancer Research
Crude fruit extracts of dwarf elder proved effective against herpes simplex virus type 1 in cell culture, with the flavonoid glycosides in the fruit identified as likely contributors to the antiviral activity.12Industrial Crops and Products. Flavonoid glycosides profiling in dwarf elder fruits (Sambucus ebulus L.) and evaluation of their antioxidant and anti-herpes simplex activities The research is early-stage, but it adds dwarf elder to a growing list of plants under investigation for antiviral compounds beyond the usual suspects.
On the cancer side, cell-culture studies have produced some intriguing results. An ethyl acetate extract of dwarf elder fruits showed lower inhibitory concentrations (meaning greater toxicity) against liver cancer and colon cancer cell lines compared to normal cell lines, suggesting a degree of selectivity for cancerous cells over healthy ones.13Pharmacognosy Magazine. Cytotoxic Effects of Ethyl Acetate Extract of Sambucus ebulus Compared With Etoposide on Normal and Cancer Cell Lines Separately, subcritical water extracts from the leaves showed cytotoxicity against lung, colon, and cervical cancer cell lines, with inhibitory concentrations in a range that researchers consider promising for further study.14Journal of Chemical Technology & Biotechnology. A new source for developing multi‐functional products: biological and chemical perspectives on subcritical water extracts of Sambucus ebulus L. The ebulin proteins in the plant, which are ribosome-inactivating proteins capable of halting cellular protein production, are believed to contribute to this anticancer activity.15PubMed Central. Ebulin from dwarf elder (Sambucus ebulus L.): a mini-review
To be clear, none of this means dwarf elder is a cancer treatment. Cell culture experiments show whether a compound can kill cancer cells in a dish, which is a very different question from whether it can safely and effectively treat cancer in a person. Many compounds that look promising in vitro fail in animal studies or human trials. These findings do, however, explain why the plant continues to attract research interest.
Antioxidant Activity and Where It Is Strongest
Not all parts of the dwarf elder plant are created equal when it comes to antioxidant capacity. A study comparing flowers, fruits, and leaves found that the leaves showed very strong antioxidant activity, outperforming even BHT, a synthetic antioxidant commonly used as a benchmark. The flowers and fruits, by contrast, had only weak antioxidant effects. The difference tracked closely with total phenolic content: leaves had the highest levels, which lines up with the phytochemical data showing leaves as the organ richest in phenolic compounds.16Marmara Pharmaceutical Journal. Antioxidant, antimicrobial and anticarcinogenic activities of Sambucus ebulus L. flowers, fruits and leaves This is a useful detail for anyone interested in the plant’s potential applications, because it means leaf-based preparations would be expected to deliver far more antioxidant benefit than fruit-based ones.
Potential for Diabetes-Related Applications
One area of research that does not have deep roots in folk tradition but has emerged from modern screening is anti-diabetic activity. Subcritical water extracts of dwarf elder showed enzyme-inhibiting effects against alpha-amylase and alpha-glucosidase, two enzymes involved in carbohydrate digestion. Blocking these enzymes slows the breakdown of starch and sugar in the gut, which in turn slows the rise of blood sugar after a meal. This is the same mechanism used by several prescription diabetes medications.17Journal of Chemical Technology & Biotechnology. A new source for developing multi‐functional products: biological and chemical perspectives on subcritical water extracts of Sambucus ebulus L. The same extracts also inhibited tyrosinase, an enzyme involved in skin pigmentation disorders, hinting at a possible cosmetic application as well. These are screening-level results, but they expand the potential use cases beyond the plant’s traditional applications.
Toxicity and Why You Should Not Eat It Raw
Here is where dwarf elder gets complicated. The plant contains ribosome-inactivating proteins, including the ebulin family, which are enzymes that attack the cellular machinery responsible for building proteins. These compounds are what make the raw plant toxic, and they are the reason dwarf elder has never been commercialized the way common elderberry has.18PubMed Central. Ebulin from dwarf elder (Sambucus ebulus L.): a mini-review Eating raw or improperly prepared berries can cause nausea, vomiting, and diarrhea, and larger quantities could theoretically cause more serious poisoning. Common elderberry (Sambucus nigra) also contains some toxic compounds in its raw form, but the levels are lower and commercial products are processed to remove them. Dwarf elder presents a harder safety challenge because its toxic proteins are more potent and the plant has not undergone the same kind of systematic food-safety evaluation.
This toxicity is also, ironically, what makes some of the plant’s compounds medically interesting. The same ribosome-inactivating proteins that make dwarf elder dangerous to eat are being studied for their potential to selectively kill cancer cells. The trick, if it ever reaches clinical application, would be targeting those proteins to cancerous tissue while keeping them away from healthy cells. That kind of targeted delivery is an active area of research in oncology more broadly, not just with dwarf elder.
Insect Repellent Properties
A more unusual line of research has explored dwarf elder as a botanical insect repellent. Leaf and flower extracts were tested against mosquito species known to carry diseases including dengue, Zika, and malaria. The phenylpropanoid-rich methanol extracts showed both toxic and repellent effects against these mosquitoes.19PubMed Central. Leaf and Flower Extracts from the Dwarf Elder (Sambucus ebulus): Toxicity and Repellence against Cosmopolitan Mosquito-Borne Diseases Vectors With growing resistance to synthetic insecticides and increasing concern about their environmental impact, plant-based alternatives are in demand. Dwarf elder’s abundance across southern Europe and western Asia, combined with its aggressive growth habit, could make it a cost-effective source for botanical insecticide development if the active compounds can be standardized.
How Dwarf Elder Grows and Spreads
Anyone who has encountered dwarf elder in the wild knows it does not behave like a typical garden plant. It is a rhizomatous perennial, meaning it spreads primarily through underground stems rather than seeds. This gives it a competitive advantage in colonizing disturbed sites, roadsides, and field margins. Studies of dwarf elder populations have found that the plant invests heavily in its belowground organs, with a shoot-to-root biomass ratio close to 1.4. It uses a strategy of rapidly producing dense stands of shoots that form a closed canopy, shading out competitors and securing the territory for the following season.20Ekológia (Bratislava). Rhizome size structure and belowground biomass of Sambucus ebulus L. populations in a monodominated plant community
This aggressive growth pattern means dwarf elder can form monoculture-like stands that suppress native vegetation. In some parts of Europe it is considered a weed, particularly on abandoned agricultural land. But the same qualities that make it invasive also make it an attractive candidate for biomass production: it grows fast, requires little care, and produces large quantities of harvestable leaf and fruit material. If future research identifies commercially viable products from the plant’s bioactive compounds, its weedy nature could shift from liability to asset.
How Dwarf Elder Compares to Common Elderberry
The distinction between Sambucus ebulus and Sambucus nigra matters because confusion between the two is common, and the consequences of that confusion are real. Common elderberry grows as a large shrub or small tree, produces drooping clusters of berries that are widely used in syrups and supplements after cooking, and is generally recognized as safe when properly prepared. Dwarf elder, by contrast, tops out at about one to two meters, dies back to the ground each winter, and holds its berry clusters upright rather than drooping. The berries look similar enough to fool casual foragers.
Chemically, the two plants share many of the same flavonoid classes, and their flavonoid concentrations in leaves and flowers are broadly similar, as the comparative data on flavonoid accumulation shows.21Bulletin of Science and Practice. Dynamics of Accumulation of Flavonoids in Different Organs of Sambucus nigra and S. ebulus But dwarf elder has higher concentrations of ribosome-inactivating proteins, which is the main reason it has not followed common elderberry into the supplement aisle. The safety gap between the two species is not about the beneficial compounds being different; it is about the toxic compounds being more abundant and potent in dwarf elder. Until extraction methods can reliably separate the useful from the harmful at a commercial scale, Sambucus ebulus will remain a research subject rather than a consumer product.
Why the Research Has Stalled at the Lab Bench
Nearly all of the published studies on dwarf elder are in vitro (cell culture) or in vivo in animals, mostly rats. No human clinical trials have been published for any application. This is a pattern common to many traditional medicinal plants from regions without large pharmaceutical research budgets. The preliminary data on wound healing, anti-inflammatory effects, and antimicrobial activity is strong enough to justify clinical investigation, but moving from animal models to human trials requires regulatory approval, significant funding, and standardized extracts, none of which are easy to secure for a plant that lacks commercial backing.
There is also a standardization problem. The chemical composition of dwarf elder varies with geography, altitude, season, and which part of the plant is harvested. Without a standardized extract, it is difficult to compare results across studies or design a clinical trial with consistent dosing. Researchers working with subcritical water extraction have made progress in producing extracts with reproducible chemical profiles, but scaling that to pharmaceutical or even nutraceutical production remains a future challenge. For now, dwarf elder sits in a familiar holding pattern: a plant with plenty of traditional use, plenty of laboratory evidence, and no approved human applications.